These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15953265)

  • 1. Methodological issues in clinical trials of drug and behavior therapies.
    Holroyd KA; Powers SW; Andrasik F
    Headache; 2005 May; 45(5):487-92. PubMed ID: 15953265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for trials of behavioral treatments for recurrent headache, first edition: American Headache Society Behavioral Clinical Trials Workgroup.
    Penzien DB; Andrasik F; Freidenberg BM; Houle TT; Lake AE; Lipchik GL; Holroyd KA; Lipton RB; McCrory DC; Nash JM; Nicholson RA; Powers SW; Rains JC; Wittrock DA;
    Headache; 2005 May; 45 Suppl 2():S110-32. PubMed ID: 15921503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodological considerations in research with special populations: children and adolescents.
    Andrasik F; Powers SW; McGrath PJ
    Headache; 2005 May; 45(5):520-5. PubMed ID: 15953269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderators and mediators of behavioral treatment for headache.
    Nicholson RA; Hursey KG; Nash JM
    Headache; 2005 May; 45(5):513-9. PubMed ID: 15953268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral headache treatment: history, review of the empirical literature, and methodological critique.
    Rains JC; Penzien DB; McCrory DC; Gray RN
    Headache; 2005 May; 45 Suppl 2():S92-109. PubMed ID: 15921506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Headache research methodology.
    Lipton RB; Bigal ME
    Headache; 2005 May; 45(5):535-7. PubMed ID: 15953271
    [No Abstract]   [Full Text] [Related]  

  • 7. Behavioral headache research: methodologic considerations and research design alternatives.
    Hursey KG; Rains JC; Penzien DB; Nash JM; Nicholson RA
    Headache; 2005 May; 45(5):466-78. PubMed ID: 15953263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose selection and comparator drugs in schizophrenia research.
    Kane JM
    J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing adherence in clinical research.
    Robiner WN
    Contemp Clin Trials; 2005 Feb; 26(1):59-77. PubMed ID: 15837453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral research and the double-blind placebo-controlled methodology: challenges in applying the biomedical standard to behavioral headache research.
    Rains JC; Penzien DB
    Headache; 2005 May; 45(5):479-86. PubMed ID: 15953264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and effectiveness approaches in behavioral treatment trials.
    Nash JM; McCrory D; Nicholson RA; Andrasik F
    Headache; 2005 May; 45(5):507-12. PubMed ID: 15953267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcoholism treatment matching research: methodological and clinical issues.
    Donovan DM; Mattson ME
    J Stud Alcohol Suppl; 1994 Dec; 12():5-14. PubMed ID: 7722998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical trials. Methodological principles and ethical aspects in the evaluation of therapies].
    Montagne O; Macquin-Mavier I; Lejonc JL
    Rev Prat; 1998 Mar; 48(6):679-84. PubMed ID: 9781143
    [No Abstract]   [Full Text] [Related]  

  • 14. Methodological and design issues in clinical trials of new neuroleptics: an overview.
    Awad AG
    Br J Psychiatry Suppl; 1993 Dec; (22):51-7. PubMed ID: 7906524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors contributing to failed trials of new agents: can technology prevent some problems?
    Greist JH; Mundt JC; Kobak K
    J Clin Psychiatry; 2002; 63 Suppl 2():8-13. PubMed ID: 15453008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for trials of behavioral treatments for recurrent headache: purpose, process, and product.
    Penzien DB
    Headache; 2005 May; 45 Suppl 2():S87-9. PubMed ID: 15921504
    [No Abstract]   [Full Text] [Related]  

  • 17. Considerations in clinical trials of combination antifungal therapy.
    Powers JH
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S228-35. PubMed ID: 15546123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assessment, monitoring, and enhancement of treatment fidelity in public health clinical trials.
    Borrelli B
    J Public Health Dent; 2011; 71 Suppl 1():S52-63. PubMed ID: 21656954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodological issues in comparative effectiveness research: clinical trials.
    Peduzzi P; Kyriakides T; O'Connor TZ; Guarino P; Warren SR; Huang GD
    Am J Med; 2010 Dec; 123(12 Suppl 1):e8-15. PubMed ID: 21184867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.